Corticosteroid (CS) therapy does not influence immune reactivity in patients with non-specific interstitial pneumonia (NSIP)

A. Zaytseva, E. Shmelev, V. Gergert (Moscow, Russian Federation)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session: Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session type: Thematic Poster Session
Number: 700
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Zaytseva, E. Shmelev, V. Gergert (Moscow, Russian Federation). Corticosteroid (CS) therapy does not influence immune reactivity in patients with non-specific interstitial pneumonia (NSIP). Eur Respir J 2012; 40: Suppl. 56, 700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB)
Source: Eur Respir J 2006; 28: Suppl. 50, 308s
Year: 2006

Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001

Non-specific interstitial pneumonia (NSIP) - a study of 12 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Peripheral blood changes in usual interstitial pneumonia (UIP) and non specific interstitial pneumonia (NSIP), possible biomarkers of oxidative stress
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Clinical presentation on nonspecific (NSIP) compared to usual (UIP) interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001

Fibrosing alveolitis in rheumatoid arthritis (FARA):a survival comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 197s
Year: 2003

Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS) development in community-acquired pneumonia (CAP)
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Histology and pathogenesis of usual interstitial pneumonia (UIP) versus nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Nonspecific interstitial pneumonia - NSIP
Source: Respipedia Article
Year: 2015

CT features of fibrosing alveolitis in rheumatoid arthritis (FARA): a comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP)
Source: Eur Respir J 2003; 22: Suppl. 45, 197s
Year: 2003

Idiopathic interstitial pneumonia (IIP) - optimal timing for initiating treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 535s
Year: 2004

Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006


Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

Clinical categorisation of idiopathic interstitial pneumonia
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005

Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Effects of empirical antibacterial therapy on the degree of systemic inflammatory response in patients with severe community-acquired pneumonia (SCAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 2s
Year: 2003

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005



Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef)
Source: Eur Respir J 2001; 18: Suppl. 33, 466s
Year: 2001